Literature DB >> 23851482

Potent monoclonal antibodies against Clostridium difficile toxin A elicited by DNA immunization.

Chunhua Zhang1, Ke Jin1, Yanling Xiao2, Ying Cheng3, Zuhu Huang1, Shixia Wang4, Shan Lu4.   

Abstract

Recent studies have demonstrated that DNA immunization is effective in eliciting antigen-specific antibody responses against a wide range of infectious disease targets. The polyclonal antibodies elicited by DNA vaccination exhibit high sensitivity to conformational epitopes and high avidity. However, there have been limited reports in literature on the production of monoclonal antibodies (mAb) by DNA immunization. Here, by using Clostridium difficile (C. diff) toxin A as a model antigen, we demonstrated that DNA immunization was effective in producing a panel of mAb that are protective against toxin A challenge and can also be used as sensitive reagents to detect toxin A from various testing samples. The immunoglobulin (Ig) gene usage for such mAb was also investigated. Further studies should be conducted to fully establish DNA immunization as a unique platform to produce mAb in various hosts.

Entities:  

Keywords:  C. difftoxin; DNA immunization; immunoglobulin genes; monoclonal antibody; toxin A

Mesh:

Substances:

Year:  2013        PMID: 23851482      PMCID: PMC3906400          DOI: 10.4161/hv.25656

Source DB:  PubMed          Journal:  Hum Vaccin Immunother        ISSN: 2164-5515            Impact factor:   3.452


  28 in total

1.  Hemagglutinin (HA) proteins from H1 and H3 serotypes of influenza A viruses require different antigen designs for the induction of optimal protective antibody responses as studied by codon-optimized HA DNA vaccines.

Authors:  Shixia Wang; Jessica Taaffe; Christopher Parker; Alicia Solórzano; Hong Cao; Adolfo García-Sastre; Shan Lu
Journal:  J Virol       Date:  2006-09-20       Impact factor: 5.103

2.  Production of monoclonal antibodies against the 8 kDa subunit of Echinococcus granulosus Antigen B (EgAgB8/2) using DNA immunization.

Authors:  Khaled M Al-Qaoud; Mariam M Al-Omari; Mohammad Al-Aghbar; Sami K Abdel-Hafez
Journal:  Hybridoma (Larchmt)       Date:  2008-12

3.  PCR fidelity of pfu DNA polymerase and other thermostable DNA polymerases.

Authors:  J Cline; J C Braman; H H Hogrefe
Journal:  Nucleic Acids Res       Date:  1996-09-15       Impact factor: 16.971

4.  Generation of a monoclonal antibody to a defined portion of the Helicobacter pylori vacuolating cytotoxin by DNA immunization.

Authors:  C Ulivieri; D Burroni; J L Telford; C T Baldari
Journal:  J Biotechnol       Date:  1996-11-01       Impact factor: 3.307

5.  Identification of two neutralizing regions on the severe acute respiratory syndrome coronavirus spike glycoprotein produced from the mammalian expression system.

Authors:  Shixia Wang; Te-hui W Chou; Pavlo V Sakhatskyy; Song Huang; John M Lawrence; Hong Cao; Xiaoyun Huang; Shan Lu
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 6.  DNA vaccines: an historical perspective and view to the future.

Authors:  Margaret A Liu
Journal:  Immunol Rev       Date:  2011-01       Impact factor: 12.988

7.  Production of anti-dengue NS1 monoclonal antibodies by DNA immunization.

Authors:  Chunya Puttikhunt; Watchara Kasinrerk; Supa Srisa-ad; Thaneeya Duangchinda; Waraporn Silakate; Seangdeun Moonsom; Nopporn Sittisombut; Prida Malasit
Journal:  J Virol Methods       Date:  2003-04       Impact factor: 2.014

8.  Heterologous HA DNA vaccine prime--inactivated influenza vaccine boost is more effective than using DNA or inactivated vaccine alone in eliciting antibody responses against H1 or H3 serotype influenza viruses.

Authors:  Shixia Wang; Chris Parker; Jessica Taaffe; Alicia Solórzano; Adolfo García-Sastre; Shan Lu
Journal:  Vaccine       Date:  2008-05-19       Impact factor: 3.641

9.  Production of monoclonal antibodies by genetic immunization.

Authors:  M A Barry; M E Barry; S A Johnston
Journal:  Biotechniques       Date:  1994-04       Impact factor: 1.993

10.  An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses.

Authors:  Alexandre Harari; Pierre-Alexandre Bart; Wolfgang Stöhr; Gonzalo Tapia; Miguel Garcia; Emmanuelle Medjitna-Rais; Séverine Burnet; Cristina Cellerai; Otto Erlwein; Tristan Barber; Christiane Moog; Peter Liljestrom; Ralf Wagner; Hans Wolf; Jean-Pierre Kraehenbuhl; Mariano Esteban; Jonathan Heeney; Marie-Joelle Frachette; James Tartaglia; Sheena McCormack; Abdel Babiker; Jonathan Weber; Giuseppe Pantaleo
Journal:  J Exp Med       Date:  2008-01-14       Impact factor: 14.307

View more
  8 in total

Review 1.  Antibodies for treatment of Clostridium difficile infection.

Authors:  David P Humphreys; Mark H Wilcox
Journal:  Clin Vaccine Immunol       Date:  2014-04-30

2.  A Combination of Three Fully Human Toxin A- and Toxin B-Specific Monoclonal Antibodies Protects against Challenge with Highly Virulent Epidemic Strains of Clostridium difficile in the Hamster Model.

Authors:  Natalie G Anosova; Leah E Cole; Lu Li; Jinrong Zhang; Anna M Brown; Sophia Mundle; Jianxin Zhang; Satyajit Ray; Fuqin Ma; Pierre Garrone; Nicola Bertraminelli; Harry Kleanthous; Stephen F Anderson
Journal:  Clin Vaccine Immunol       Date:  2015-04-29

3.  Using DNA Immunization to Elicit Monoclonal Antibodies in Mice, Rabbits, and Humans.

Authors:  Shuying Liu; Shixia Wang; Shan Lu
Journal:  Hum Gene Ther       Date:  2018-09       Impact factor: 5.695

Review 4.  An update on antibody-based immunotherapies for Clostridium difficile infection.

Authors:  Greg Hussack; Jamshid Tanha
Journal:  Clin Exp Gastroenterol       Date:  2016-08-01

Review 5.  Conventional and alternative treatment approaches for Clostridium difficile infection.

Authors:  Khalid M Aljarallah
Journal:  Int J Health Sci (Qassim)       Date:  2017 Jan-Mar

6.  Generation and characterization of novel anti-DR4 and anti-DR5 antibodies developed by genetic immunization.

Authors:  Agathe Dubuisson; Cécile Favreau; Eric Fourmaux; Sabrina Lareure; Rafael Rodrigues-Saraiva; Catherine Pellat-Deceunynck; Said El Alaoui; Olivier Micheau
Journal:  Cell Death Dis       Date:  2019-02-04       Impact factor: 8.469

Review 7.  Application of recombinant antibodies for treatment of Clostridioides difficile infection: Current status and future perspective.

Authors:  Hamideh Raeisi; Masoumeh Azimirad; Ali Nabavi-Rad; Hamid Asadzadeh Aghdaei; Abbas Yadegar; Mohammad Reza Zali
Journal:  Front Immunol       Date:  2022-08-23       Impact factor: 8.786

Review 8.  DNA immunization as a technology platform for monoclonal antibody induction.

Authors:  Shuying Liu; Shixia Wang; Shan Lu
Journal:  Emerg Microbes Infect       Date:  2016-04-06       Impact factor: 7.163

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.